Participation in research: the economic advantages in a haemophilia research population

Haemophilia. 2000 Sep;6(5):571-4. doi: 10.1046/j.1365-2516.2000.00409.x.
No abstract available

MeSH terms

  • Anti-HIV Agents / economics
  • Anti-HIV Agents / therapeutic use
  • Clinical Protocols
  • Cost Control
  • Drug Costs
  • Factor IX / economics
  • Factor IX / therapeutic use
  • Factor VIII / economics
  • Factor VIII / therapeutic use
  • Health Care Costs*
  • Hemophilia A / economics*
  • Hemophilia A / virology
  • Hemophilia B / economics
  • Hemophilia B / virology
  • Humans
  • Recombinant Proteins / economics
  • Recombinant Proteins / therapeutic use
  • Research / economics*

Substances

  • Anti-HIV Agents
  • Recombinant Proteins
  • Factor VIII
  • Factor IX